InvestorsHub Logo
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

Re: rajaram46 post# 1529

Monday, 10/23/2017 12:47:58 PM

Monday, October 23, 2017 12:47:58 PM

Post# of 2933
The EDP-305 phase-1/1b data are everything investors could have wanted at this stage, IMO.

The phase-2 trial in NASH patients, which begins in 2018, will be the first test of efficacy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News